-65.7%
MRNA vs LNT
+31.4%
-97.1%
-95.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | LNT | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | 0.0% | +5.4% | +5.4% |
| 7D | -1.1% | -1.0% | 0.0% | -0.8% |
| 30D | +126.1% | -4.2% | +130.4% | +128.6% |
| 3M | +190.0% | -6.7% | +196.7% | +194.8% |
| 6M | +157.2% | -3.6% | +160.8% | +158.7% |
| YTD | +388.2% | +5.9% | +382.3% | +379.3% |
| 1Y | +467.0% | +7.3% | +459.8% | +455.9% |
| 3Y | +36.1% | +46.5% | -10.4% | +20.5% |
| All | -65.7% | +31.4% | -97.1% | -70.5% |
Cumulative growth
Daily Returns
Daily percentage return beside LNT.
Daily Out/Under-Performance
Portfolio return minus LNT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LNT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded LNT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling